Department of Surgery, Division of Surgical Oncology, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University, Wexner Medical Center, Columbus, OH, USA.
National Clinician Scholars Program at the Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
Ann Surg Oncol. 2021 Oct;28(11):6309-6316. doi: 10.1245/s10434-021-09911-1. Epub 2021 Apr 12.
Patients can experience barriers and disparities to access high-quality cancer care. This study sought to characterize receipt of surgery and chemotherapy among Medicare beneficiaries with a diagnosis of early-stage pancreatic adenocarcinoma cancer (PDAC) relative to race/ethnicity and social vulnerability.
The Surveillance, Epidemiology, and End Results (SEER)-Medicare database was used to identify patients with a diagnosis of early-stage (stage 1 or 2) PDAC between 2004 and 2016. Data were merged with the CDC's Social Vulnerability Index (SVI) at the beneficiary's county of residence. Multivariable, mixed-effects logistic regression was used to assess the association of SVI with resection.
Among 15,931 older Medicare beneficiaries with early-stage PDAC (median age, 77 years; interquartile range [IQR], 71-82 years), the majority was White (n = 12,737, 80.0 %), whereas a smaller subset was Black or Latino (n = 3194, 20.0 %) A minority of patients was more likely to live in highly vulnerable communities (low SVI: white [90.5 %] vs minority [9.5 %] vs high SVI: white [71.9 %] vs minority [28.1 %]; p < 0.001). Use of resection for early-stage PDAC was lowest among the patients who resided in high-SVI areas (low [38.0 %] vs average [34.3 %] vs high [31.9 %]; p < 0.001). The minority patients were less likely to undergo resection than the White patients (no resection: white [64.1 %] vs minority [70.7 %]; p < 0.001). The median SVI was higher among the patients who underwent resection (57.6; IQR, 36.0-81.0) than among those who did not (60.4; IQR, 41.9-84.3), and increased SVI resulted in a decline in the likelihood of resection (SVI trend: OR, 0.98; 95 % confidence interval [CI], 0.97-1.00), especially among the minority patients. Minority patients from high-SVI counties had markedly lower odds of preoperative chemotherapy than minority patients from a low-SVI neighborhood (OR, 0.62; 95 % CI, 0.52-0.73).
Older Medicare beneficiaries with early-stage PDAC residing in counties with higher social vulnerability had lower odds of undergoing pancreatic resection, which was more pronounced among minority versus older White Medicare beneficiaries.
患者在获得高质量癌症治疗方面可能会遇到障碍和差异。本研究旨在描述医疗保险受益人与种族/族裔和社会脆弱性相关的早期胰腺癌(PDAC)的手术和化疗接受情况。
使用监测、流行病学和最终结果(SEER)-医疗保险数据库来确定在 2004 年至 2016 年间诊断为早期(I 期或 II 期)PDAC 的患者。数据与疾病预防控制中心(CDC)的社会脆弱性指数(SVI)在受益人的县居住地进行合并。采用多变量混合效应逻辑回归来评估 SVI 与切除术之间的关联。
在 15931 名患有早期 PDAC 的老年医疗保险受益人中(中位年龄为 77 岁;四分位间距 [IQR],71-82 岁),大多数为白人(n=12737,80.0%),而较小的一部分为黑人或拉丁裔(n=3194,20.0%)。少数患者更有可能居住在高脆弱性社区(低 SVI:白人[90.5%]与少数族裔[9.5%];高 SVI:白人[71.9%]与少数族裔[28.1%];p<0.001)。接受早期 PDAC 切除术的患者中,居住在高 SVI 地区的患者比例最低(低 SVI:38.0%;平均 SVI:34.3%;高 SVI:31.9%;p<0.001)。少数民族患者接受切除术的可能性低于白人患者(未行切除术:白人[64.1%]与少数民族[70.7%];p<0.001)。接受切除术的患者的平均 SVI 中位数较高(57.6;IQR,36.0-81.0),而未接受切除术的患者的平均 SVI 中位数较高(60.4;IQR,41.9-84.3),SVI 升高会降低切除术的可能性(SVI 趋势:OR,0.98;95%置信区间 [CI],0.97-1.00),尤其是在少数民族患者中。来自高 SVI 县的少数民族患者接受术前化疗的可能性明显低于来自低 SVI 社区的少数民族患者(OR,0.62;95%CI,0.52-0.73)。
患有早期 PDAC 的老年医疗保险受益人居住在社会脆弱性较高的县,接受胰腺切除术的可能性较低,而与老年白人医疗保险受益人相比,少数民族患者的这种可能性更为明显。